Epilepsy in paediatric patients with schizencephaly

Ilona Kopyta1, Michał Skrzypek2, Dorota Raczkiewicz3

  • 1Department of Paediatric Neurology, School of Medicine, Medical University of Silesia, Katowice, Poland.

Insights

Bilateral schizencephaly significantly increases the risk of seizures in children. This type of central nervous system disorder is a key factor in developing epilepsy, even drug-resistant forms.

Area of Science:

  • Neurology
  • Developmental Neuroscience
  • Pediatric Neurology

Background:

  • Schizencephaly is a rare congenital central nervous system (CNS) disorder.
  • Known causes include prenatal infections, toxic exposures, and certain medications.
  • It is classified as a neuronal migration disorder.

Purpose of the Study:

  • To investigate the clinical presentation of schizencephaly.
  • To specifically analyze the epilepsy course in pediatric patients with schizencephaly.

Main Methods:

  • Retrospective analysis of 38 children diagnosed with schizencephaly.
  • Statistical analysis using SAS 9.4, including U Mann-Whitney, chi-squared tests, and logistic regression.
  • Assessment of epilepsy prevalence and characteristics.

Main Results:

  • Epilepsy was most common in bilateral type II schizencephaly.
  • Bilateral open schizencephaly was a significant risk factor for seizures (OR=11.67).
  • Drug-resistant epilepsy occurred in 45% of affected children; prevalence was not linked to gender, development, or other CNS defects.

Conclusions:

  • Bilateral schizencephaly is an independent risk factor for epilepsy in children.
  • Understanding these risk factors is crucial for managing pediatric neurological conditions.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.4K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
989
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
505
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
776